Itay Weinstein
Financieel Directeur/CFO bij XTL BIOPHARMACEUTICALS LTD.
Profiel
Mr. Itay Weinstein, CPA, is a Chief Financial Officer at XTL Biopharmaceuticals Ltd.
and a Partner at Yosef Shimony CPA.
He is on the Board of Directors at Uno Management & Consulting Ltd.
Mr. Weinstein was previously employed as a Controller by Upsellon Brands Holdings Ltd., a Chief Financial Officer by OphthaliX, Inc., a Controller by Can-Fite BioPharma Ltd., an Auditor by Oren Horowitz & Co., and a Chief Financial Officer by Wize Pharma, Inc. He received his undergraduate degree from Tel-Aviv University.
Actieve functies van Itay Weinstein
| Bedrijven | Functie | Begin |
|---|---|---|
| XTL BIOPHARMACEUTICALS LTD. | Financieel Directeur/CFO | 01-07-2017 |
| Uno Management & Consulting Ltd. | Directeur/Bestuurslid | - |
Yosef Shimony CPA
 Yosef Shimony CPA Miscellaneous Commercial ServicesCommercial Services Yosef Shimony CPA is an accounting firm that offers a range of accounting services, including financial reports, bookkeeping, and salary processing. Yosef Shimony CPA is based in Ramat Gan, Israel, with another office located in Bnei Brak. The company caters to various clients, such as Israeli and international companies, public and private companies, and venture capital funds. The company also provides professional due diligence experience on accounting and taxes. | Corporate Officer/Principal | 01-01-1999 |
Eerdere bekende functies van Itay Weinstein
| Bedrijven | Functie | Einde |
|---|---|---|
| MAWSON INFRASTRUCTURE GROUP INC. | Financieel Directeur/CFO | 16-11-2017 |
OphthaliX, Inc.
 OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Financieel Directeur/CFO | 01-11-2017 |
| Oren Horowitz & Co. | Comptroller/Controller/Auditor | - |
| CAN-FITE BIOPHARMA LTD. | Comptroller/Controller/Auditor | - |
| UPSELLON BRANDS HOLDINGS LTD | Comptroller/Controller/Auditor | - |
Opleiding van Itay Weinstein
| Tel-Aviv University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| XTL BIOPHARMACEUTICALS LTD. | Health Technology |
| CAN-FITE BIOPHARMA LTD. | Health Technology |
| UPSELLON BRANDS HOLDINGS LTD | Retail Trade |
| Bedrijven in privébezit | 5 |
|---|---|
OphthaliX, Inc.
OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Health Technology |
| Uno Management & Consulting Ltd. | |
Yosef Shimony CPA
Yosef Shimony CPA Miscellaneous Commercial ServicesCommercial Services Yosef Shimony CPA is an accounting firm that offers a range of accounting services, including financial reports, bookkeeping, and salary processing. Yosef Shimony CPA is based in Ramat Gan, Israel, with another office located in Bnei Brak. The company caters to various clients, such as Israeli and international companies, public and private companies, and venture capital funds. The company also provides professional due diligence experience on accounting and taxes. | Commercial Services |
| Oren Horowitz & Co. | |
Wize Pharma, Inc.
 Wize Pharma, Inc. Pharmaceuticals: MajorHealth Technology Wize Pharma, Inc. develops, produces and sells electronic and electro-optical systems. It focuses on treatment of ophthalmic disorders including Dry Eye Syndrome and other inflammatory conditions. The company holds rights to purchase, market, sell, and distribute LO2A. The company was founded on December 10, 1999 and is headquartered in Hod Ha'Sharon, Israel. | Health Technology |